Lokpal Bhatia

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Hepatology · 2014 · 306 citations

Pathology, Epa Enrichment, Fatty Liver Disease +18

Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial

Eleonora Scorletti, Annette L. West, Lokpal Bhatia et al. · Journal of Hepatology · 2015 · 108 citations

Metabolic Syndrome, Hepatology, Metabolic Associated Steatotic Liver Disease +13

Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression

Lokpal Bhatia, Eleonora Scorletti, Geraldine Clough et al. · Atherosclerosis · 2015 · 65 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +11

Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Contemporary Clinical Trials · 2014 · 44 citations

Obesity, Metabolic Syndrome, Hepatology +9

Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial

Keith McCormick, Eleonora Scorletti, Lokpal Bhatia et al. · Diabetologia · 2015 · 19 citations · Full text

Obesity, Metabolic Syndrome, Hepatology +13